Related Experiment Video
Updated: Jun 5, 2026

Establishment of Deep Hypothermic Circulatory Arrest in Rats
Published on: December 16, 2022
Cartap Hydrochloride Poisoning: Rarely Seen, Rarely Heard
Samata Chororia1, Satyabrata Guru1, Upendra Hansda1
1Department of Trauma and Emergency, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
Abstract:
Cartap hydrochloride (CH) is a Class II hazardous pesticide that causes toxicity by inhibiting post-synaptic nicotinic acetylcholine receptors and affecting calcium release in the sarcoplasmic reticulum. While mortality is generally low, severe cases can lead to respiratory failure. A 25-year-old male presented to the emergency department six hours after intentionally consuming approximately 12 g of 50% CH. He exhibited vomiting, drowsiness (Glasgow Coma Score [GCS]: 13/15), and bradycardia (HR: 52/min). Initial arterial blood gas (ABG) analysis revealed mixed acidosis (pH: 7.296, pCO2: 60.8, pO2: 102.8, Lactate: 4.2, and HCO3: 20.3). Notably, serum pseudo-cholinesterase levels and other laboratory findings were within normal limits. The patient was treated with non-invasive ventilation (NIV) for respiratory acidosis and administered a loading dose of N-acetylcysteine (NAC) (150 mg/kg) along with symptomatic management. His sensorium and ABG parameters normalized within six hours of treatment. He remained asymptomatic and was discharged after three days. Human toxicity from CH is rarely reported, and cases involving mixed acidosis are particularly sparse in literature. This case highlights the importance of recognizing CH poisoning, which can mimic organophosphate toxicity. Vigilant monitoring for acidosis via ABG and early intervention with NAC and supportive care, such as NIV, are crucial for successful clinical outcomes.
More Related Videos
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Prevention of Further Absorption of Poison
Toxidromes: Clinical Features
Drug Toxicity: Overview

